Lærke S. Gasbjerg

Separate and Combined Glucometabolic Effects of Endogenous Glucose-Dependent Insulinotropic Polypeptide and Glucagon-like Peptide 1 in Healthy Individuals

Lærke S. Gasbjerg, Mads M. Helsted, Bolette Hartmann et al. · Diabetes · 2019 · 187 citations

Medicine, Endocrinology, Pharmacology +17

Effects of combined GIP and GLP-1 infusion on energy intake, appetite and energy expenditure in overweight/obese individuals: a randomised, crossover study

Natasha C. Bergmann, Asger Lund, Lærke S. Gasbjerg et al. · Diabetologia · 2019 · 135 citations · Full text

Life Sciences, Nutrition, Nutritional Sciences +17

The Gluco- and Liporegulatory and Vasodilatory Effects of Glucose-Dependent Insulinotropic Polypeptide (GIP) Are Abolished by an Antagonist of the Human GIP Receptor

Meena Asmar, Ali Asmar, Lene Simonsen et al. · Diabetes · 2017 · 128 citations

Medicine, Physiology, Diabetology +8

Human GIP(3-30)NH2 inhibits G protein-dependent as well as G protein-independent signaling and is selective for the GIP receptor with high-affinity binding to primate but not rodent GIP receptors

M Gabe, Alexander H. Sparre‐Ulrich, Mie Fabricius Pedersen et al. · Biochemical Pharmacology · 2018 · 101 citations

Life Sciences, Molecular Biology, Pharmacology +13

GIP(3-30)NH2 is an efficacious GIP receptor antagonist in humans: a randomised, double-blinded, placebo-controlled, crossover study

Lærke S. Gasbjerg, Mikkel Christensen, Bolette Hartmann et al. · Diabetologia · 2017 · 99 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +4